Financhill
Buy
78

ALBKY Quote, Financials, Valuation and Earnings

Last price:
$0.66
Seasonality move :
8.6%
Day range:
$0.64 - $0.68
52-week range:
$0.34 - $0.68
Dividend yield:
1.06%
P/E ratio:
9.25x
P/S ratio:
2.57x
P/B ratio:
0.72x
Volume:
1.8M
Avg. volume:
107.5K
1-year change:
51.72%
Market cap:
$6.1B
Revenue:
$2.4B
EPS (TTM):
$0.07
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.9B -$310.7M $1.9B $2.3B $2.4B
Revenue Growth (YoY) 12.42% -- -- 23.32% 4.58%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $319.6M $334.9M $210M $166.7M $144M
Other Inc / (Exp) $799.3M $167.9M $767.8K $6.5M $43.3M
Operating Expenses $1.2B $1.2B $923.5M $872.6M $957.9M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $127.2M -$3.5B $573.6M $844.4M $883.2M
Earnings of Discontinued Ops. $3.2M -$39.2M $66.9M $69.3M $61.7M
Income Tax Expense $11.6M -$66M $252M $244.7M $237M
Net Income to Company $127.2M -$3.5B $573.6M $844.4M $883.2M
 
Minority Interest in Earnings -$237.5K -$101.8K -$323.8K -- --
Net Income to Common Excl Extra Items $118.5M -$3.4B $388.2M $669.1M $707.9M
 
Basic EPS (Cont. Ops) $0.02 -$0.45 $0.04 $0.07 $0.07
Diluted EPS (Cont. Ops) $0.02 -$0.45 $0.04 $0.07 $0.07
Weighted Average Basic Share $6.2B $7.7B $9.4B $9.4B $9.3B
Weighted Average Diluted Share $6.2B $7.7B $9.4B $9.4B $9.3B
 
EBITDA -- -- -- -- --
EBIT $732M -$2.9B $1.1B $2.9B $3.9B
 
Revenue (Reported) $2.9B -$310.7M $1.9B $2.3B $2.4B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $732M -$2.9B $1.1B $2.9B $3.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.1B $447.4M $345.3M $612.6M $604.8M
Revenue Growth (YoY) 56.24% -57.71% -22.81% 77.37% -1.26%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $88.7M $93.3M $25.6M $18.5M $44M
Other Inc / (Exp) $509M $46.4M $23M -$6.2M $32.9M
Operating Expenses $365.6M $327.5M $185.2M $155.9M $277.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$40.3M -$475.8M $43.6M $167.6M $208.3M
Earnings of Discontinued Ops. -- -$35.3M $47.1M $11.7M -$3.9M
Income Tax Expense -$1.8M -$44.3M $29.8M $49.7M $28.8M
Net Income to Company -$42.6M -$502.5M $68.6M $164.6M $200.7M
 
Minority Interest in Earnings -$93K -$41.2K -$23.5K $189.5K $190.8K
Net Income to Common Excl Extra Items -$35.3M -$466.8M $60.8M $129.8M $175.8M
 
Basic EPS (Cont. Ops) -$0.01 -$0.03 $0.01 $0.01 $0.02
Diluted EPS (Cont. Ops) -$0.01 -$0.03 $0.01 $0.01 $0.02
Weighted Average Basic Share $6.2B $9.4B $9.4B $9.4B $9.1B
Weighted Average Diluted Share $6.2B $9.4B $9.4B $9.4B $9.1B
 
EBITDA -- -- -- -- --
EBIT $100.2M -$321.8M $134.2M $780.7M $961.4M
 
Revenue (Reported) $1.1B $447.4M $345.3M $612.6M $604.8M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $100.2M -$321.8M $134.2M $780.7M $961.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.9B -$347.3M $2.2B $2.3B $2.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $320M $336.2M $215.3M $172M $146.8M
Other Inc / (Exp) $813M $168.4M $621.8K $6.7M $43M
Operating Expenses $1.2B $1.2B $939.6M $875.8M $1B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $124.8M -$3.5B $576.8M $840.6M $890.8M
Earnings of Discontinued Ops. -- -$38.1M $65.3M $74.2M $61.4M
Income Tax Expense $13.3M -$63.1M $249.2M $244.7M $245.1M
Net Income to Company $127.2M -$3.5B $573.6M $844.4M $883.2M
 
Minority Interest in Earnings -$240.1K -$101.4K -$322.7K -$1.2K -$4.1K
Net Income to Common Excl Extra Items $114.6M -$3.5B $392.5M $670.1M $707.1M
 
Basic EPS (Cont. Ops) $0.02 -$0.51 $0.04 $0.07 $0.07
Diluted EPS (Cont. Ops) $0.02 -$0.51 $0.04 $0.07 $0.07
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT $728.1M -$2.9B $1.1B $2.9B $3.9B
 
Revenue (Reported) $2.9B -$347.3M $2.2B $2.3B $2.4B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $728.1M -$2.9B $1.1B $2.9B $3.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue -$347.3M $2.2B $2.3B $2.4B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $336.2M $215.3M $172M $146.8M --
Other Inc / (Exp) $168.4M $621.8K $6.7M $43M --
Operating Expenses $1.2B $939.6M $875.8M $1B --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$3.5B $576.8M $840.6M $890.8M --
Earnings of Discontinued Ops. -$38.1M $65.3M $74.2M $61.4M --
Income Tax Expense -$63.1M $249.2M $244.7M $245.1M --
Net Income to Company -$3.5B $573.6M $844.4M $883.2M --
 
Minority Interest in Earnings -$101.4K -$322.7K -$1.2K -$4.1K --
Net Income to Common Excl Extra Items -$3.5B $392.5M $670.1M $707.1M --
 
Basic EPS (Cont. Ops) -$0.51 $0.04 $0.07 $0.07 --
Diluted EPS (Cont. Ops) -$0.51 $0.04 $0.07 $0.07 --
Weighted Average Basic Share $30.9B $37.6B $37.6B $37B --
Weighted Average Diluted Share $30.9B $37.6B $37.6B $37.1B --
 
EBITDA -- -- -- -- --
EBIT -$2.9B $1.1B $2.9B $3.9B --
 
Revenue (Reported) -$347.3M $2.2B $2.3B $2.4B --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -$2.9B $1.1B $2.9B $3.9B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $11.1B $15.4B $15.4B $5.3B $3.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $275.2M $328.9M $278.1M $218.9M $249.7M
Other Current Assets -- -- -- -- --
Total Current Assets $13.2B $23.9B $23.8B $12.4B $10.5B
 
Property Plant And Equipment $979.5M $835.4M $567.5M $553.8M $555.7M
Long-Term Investments $14B $13.2B $16.9B $18.7B $19.6B
Goodwill $73.4M -- -- -- --
Other Intangibles $663.7M $541.4M $509.1M $516.2M $455.8M
Other Long-Term Assets -- -- -- -- --
Total Assets $86.1B $83.1B $83.7B $80.1B $75B
 
Accounts Payable $352.1M $321.9M $299.2M $235.5M $247.7M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $438.3M $389.4M $323.8M $265.3M $348.6M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $75.9B $76.2B $76.9B $72B $66.5B
 
Common Stock $569.6M $796.8M $730.3M $753.9M $709.7M
Other Common Equity Adj -- -- -- -- --
Common Equity $10.3B $6.9B $6.7B $8.1B $8.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $36.1M $33.3M $19.7M $19.9M $16.6M
Total Equity $10.3B $6.9B $6.7B $8.1B $8.5B
 
Total Liabilities and Equity $86.1B $83.1B $83.7B $80.1B $75B
Cash and Short Terms $11.1B $15.4B $15.4B $5.3B $3.4B
Total Debt $2.4B $3.7B $3.8B $3.8B $3.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $11.1B $15.4B $15.4B $5.3B $3.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $275.2M $328.9M $278.1M $218.9M $249.7M
Other Current Assets -- -- -- -- --
Total Current Assets $13.2B $23.9B $23.8B $12.4B $10.5B
 
Property Plant And Equipment $979.5M $835.4M $567.5M $553.8M $555.7M
Long-Term Investments $14B $13.2B $16.9B $18.7B $19.6B
Goodwill $73.4M -- -- -- --
Other Intangibles $663.7M $541.4M $509.1M $516.2M $455.8M
Other Long-Term Assets -- -- -- -- --
Total Assets $86.1B $83.1B $83.7B $80.1B $75B
 
Accounts Payable $352.1M $321.9M $299.2M $235.5M $247.7M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $438.3M $389.4M $323.8M $265.3M $348.6M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $75.9B $76.2B $76.9B $72B $66.5B
 
Common Stock $569.6M $796.8M $730.3M $753.9M $709.7M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $36.1M $33.3M $19.7M $19.9M $16.6M
Total Equity $10.3B $6.9B $6.7B $8.1B $8.5B
 
Total Liabilities and Equity $86.1B $83.1B $83.7B $80.1B $75B
Cash and Short Terms $11.1B $15.4B $15.4B $5.3B $3.4B
Total Debt $2.4B $3.7B $3.8B $3.8B $3.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $127.2M -$3.5B $573.6M $844.4M $883.2M
Depreciation & Amoritzation $202.8M $313.1M $217.7M $188.4M $224M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $6.4B $4.4B $2.7B -$5.8B -$876.7M
 
Capital Expenditures -- $190.1M $143.2M $162.4M $165.6M
Cash Acquisitions -$48.6M $138.3M $228.8M $399.5M $264.1M
Cash From Investing -$1.2B -$909.3M -$3.1B -$3.1B -$999M
 
Dividends Paid (Ex Special Dividend) -- -- -$3.2M -$1.1M -$66M
Special Dividend Paid
Long-Term Debt Issued $565.7M $1.6B $869.5M $664.7M $1.1B
Long-Term Debt Repaid -$447M -$24.7M -$391.4M -$577M -$832.3M
Repurchase of Common Stock -- -- -- -$8.7M -$59.5M
Other Financing Activities -$2.3M -$8.4M -$10.3M $526.1M $265.2M
Cash From Financing $49.8M $2.4B $340.3M $438.5M $152.6M
 
Beginning Cash (CF) $3.9B $9.4B $13.1B $13.2B $4.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.2B $5.9B -$239.5M -$8.4B -$1.5B
Ending Cash (CF) $9.1B $15.2B $12.8B $4.8B $3.3B
 
Levered Free Cash Flow $6.4B $4.2B $2.5B -$6B -$1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$42.6M -$502.5M $68.6M $164.6M $200.7M
Depreciation & Amoritzation $66.5M $124.8M $49.5M $72.3M $80.8M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2.4B -$176.7M $364.6M -$1.7B -$501.6M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions $6.9M $20M $12.4M $13.9M $253.3M
Cash From Investing $804M $33.2M -$533.8M -$923.4M -$45.5M
 
Dividends Paid (Ex Special Dividend) -- -- $1.4M -$1.1M $1.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$14.1M $472.3M -- $50.4M $78.9M
Long-Term Debt Repaid -$432.3M -$7.2M -$389M $3.5M -$426.7M
Repurchase of Common Stock -- -- -- -$7.4M -$26.3M
Other Financing Activities -- -$1.6M $14.2M $128.3M -$5.9M
Cash From Financing -$342.1M $426.6M $467.9M $127.2M -$394.2M
 
Beginning Cash (CF) $6.3B $14.9B $12.6B $7.8B $4.5B
Foreign Exchange Rate Adjustment $520.7K -$9M $43.4K $2.6M $2.2M
Additions / Reductions $2.9B $270.2M $184.6M -$2.4B -$1.1B
Ending Cash (CF) $9.1B $15.2B $12.8B $4.8B $3.3B
 
Levered Free Cash Flow $2.4B -$176.7M $364.6M -$1.7B -$501.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $127.2M -$3.5B $573.6M $844.4M $883.2M
Depreciation & Amoritzation $202.8M $313.1M $217.7M $188.4M $224M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $6.4B $4.4B $2.7B -$5.8B -$876.7M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -$48.6M $138.3M $228.8M $399.5M $264.1M
Cash From Investing -$1.2B -$909.3M -$3.1B -$3.1B -$999M
 
Dividends Paid (Ex Special Dividend) -- -- -$3.2M -$1.1M -$66M
Special Dividend Paid
Long-Term Debt Issued $565.7M $1.6B -- $664.7M $1.1B
Long-Term Debt Repaid -- -$24.7M -- -$577M -$832.3M
Repurchase of Common Stock -- -- -- -- -$59.5M
Other Financing Activities -- -$8.4M -$10.3M $526.1M $265.2M
Cash From Financing $49.8M $2.4B $340.3M $438.5M $152.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.2B $5.9B -$239.5M -$8.4B -$1.5B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.4B $4.4B $2.7B -$5.8B -$876.7M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$3.5B $573.6M $844.4M $883.2M --
Depreciation & Amoritzation $313.1M $217.7M $188.4M $224M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $4.4B $2.7B -$5.8B -$876.7M --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions $138.3M $228.8M $399.5M $264.1M --
Cash From Investing -$909.3M -$3.1B -$3.1B -$999M --
 
Dividends Paid (Ex Special Dividend) -- -$3.2M -$1.1M -$66M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.6B -- $664.7M $1.1B --
Long-Term Debt Repaid -$24.7M -$391.4M -$577M -$832.3M --
Repurchase of Common Stock -- -- -$8.7M -$59.5M --
Other Financing Activities -$8.4M -$10.3M $526.1M $265.2M --
Cash From Financing $2.4B $340.3M $438.5M $152.6M --
 
Beginning Cash (CF) $49.2B $53B $36.5B $18.8B --
Foreign Exchange Rate Adjustment -$4.5M -$965K $2.2M $4.3M --
Additions / Reductions $5.9B -$239.5M -$8.4B -$1.5B --
Ending Cash (CF) $54.8B $51.4B $28.2B $17.3B --
 
Levered Free Cash Flow $4.4B $2.7B -$5.8B -$876.7M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock